000 | 01295 a2200325 4500 | ||
---|---|---|---|
005 | 20250513223057.0 | ||
264 | 0 | _c20001121 | |
008 | 200011s 0 0 eng d | ||
022 | _a0003-4967 | ||
024 | 7 |
_a10.1136/ard.59.suppl_1.i54 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFoxwell, B M | |
245 | 0 | 0 |
_aAdenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production. _h[electronic resource] |
260 |
_bAnnals of the rheumatic diseases _cNov 2000 |
||
300 |
_ai54-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdenoviridae _xgenetics |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xphysiopathology |
650 | 0 | 4 | _aGene Transfer Techniques |
650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNF-kappa B _xphysiology |
650 | 0 | 4 | _aTransgenes |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
700 | 1 | _aBondeson, J | |
700 | 1 | _aBrennan, F | |
700 | 1 | _aFeldmann, M | |
773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 59 Suppl 1 _gp. i54-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.59.suppl_1.i54 _zAvailable from publisher's website |
999 |
_c10995874 _d10995874 |